Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET

RICHMOND, Va., April 7, 2008 AlbemarleCorporation (NYSE: ALB) will hold its quarterly conference call to discussfirst quarter results on Tuesday, April 22, 2008, at 9:00am ET.

This call is being webcast by Thomson/CCBN and can be accessed atAlbemarle Corporation's Web site at www.albemarle.com in the InvestorInformation section.

The webcast is also being distributed through the Thomson StreetEventsNetwork to both institutional and individual investors. Individual investorscan listen to the call at www.earnings.com, Thomson/CCBN's individual investorportal, powered by StreetEvents. Institutional investors can access the callvia Thomson's password-protected event management site, StreetEvents(www.streetevents.com).

Albemarle Corporation, headquartered in Richmond, Virginia, is a leadingproducer of specialty chemicals for consumer electronics; transportation andindustrial products; pharmaceuticals; agricultural products; construction andpackaging materials. The company's three business segments, Polymer Additives,Catalysts and Fine Chemicals (which includes custom manufacturing services forthe life sciences market) serve customers in nearly 100 countries, generatingannual revenue of approximately $2.4 billion. Learn more about Albemarle athttp://www.albemarle.com .To listen to this conference, please call the following: Dial In # 800-591-6942 International Dial In # 617-614-4909 Passcode 21020519 A replay of this call will be available beginning at 11:00AM ET April 22, 2008 and will play until April 29, 2008 at the following number: Dial In # 888-286-8010 International Dial In # 617-801-6888 Passcode 74513981

SOURCE Albemarle Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...